The Use of Paclitaxel and Platinum-Based Chemotherapy in Uterine Papillary Serous Carcinoma
- 1 August 1999
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 74 (2) , 272-277
- https://doi.org/10.1006/gyno.1999.5444
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- PaclitaxelDrugs & Aging, 1998
- Endometrial Papillary Serous Carcinoma: Patterns of Spread and TreatmentClinical Obstetrics and Gynecology, 1996
- Neoadjuvant Chemotherapy in Uterine Papillary Serous CarcinomaGynecologic Oncology, 1996
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Uterine Papillary Serous Carcinoma (UPSC): A Clinicopathologic Study of 30 CasesGynecologic Oncology, 1995
- Death Rate and Recurrence Pattern among 841 Clinical Stage I Endometrial Cancer Patients with Special Reference to Uterine Papillary Serous CarcinomaGynecologic Oncology, 1993
- Intravenous Cisplatin, Doxorubicin, and Cyclophosphamide in the Treatment of Uterine Papillary Serous Carcinoma (UPSC)Gynecologic Oncology, 1993
- Uterine papillary serous carcinoma: A study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinomaGynecologic Oncology, 1992
- Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC)Gynecologic Oncology, 1992
- Virulence of papillary endometrial carcinomaInternational Journal of Gynecology & Obstetrics, 1990